NM_001904.4:c.37G>A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_001904.4(CTNNB1):​c.37G>A​(p.Ala13Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

CTNNB1
NM_001904.4 missense

Scores

3
5
11

Clinical Significance

Likely pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 10.0

Publications

23 publications found
Variant links:
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
  • exudative vitreoretinopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • severe intellectual disability-progressive spastic diplegia syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
  • exudative vitreoretinopathy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28936157).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTNNB1NM_001904.4 linkc.37G>A p.Ala13Thr missense_variant Exon 3 of 15 ENST00000349496.11 NP_001895.1 P35222A0A024R2Q3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTNNB1ENST00000349496.11 linkc.37G>A p.Ala13Thr missense_variant Exon 3 of 15 1 NM_001904.4 ENSP00000344456.5 P35222
CTNNB1ENST00000645982.1 linkc.37G>A p.Ala13Thr missense_variant Exon 3 of 16 ENSP00000494845.1 P35222
CTNNB1ENST00000715152.1 linkn.37G>A non_coding_transcript_exon_variant Exon 3 of 16 ENSP00000520353.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Melanoma Pathogenic:1
Jul 14, 2015
Database of Curated Mutations (DoCM)
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Uncertain
0.085
D
BayesDel_noAF
Benign
-0.12
CADD
Uncertain
26
DANN
Uncertain
0.98
DEOGEN2
Benign
0.39
T;T;T;T;T;T;T;T;T;T;T;T;.;T;T;T;T;T;.;T;T;T;T;.;.;.;T;T;.;T;T;T;T;.;T;T;T;T;T;T;T
Eigen
Benign
0.16
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.97
.;D;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;.;D;.;.;.;.;T;D;D;.;.;D;.;.;.;.;D;.;D;.;.;.;.;D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.29
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;.;N;.;N;N;N;N;N;.;N;N;.;.;N;N;N;.;.;.;.;N;N;.;.;.;N;.;.;N;N;.;N;.;N;.;N;N;N;N;N
PhyloP100
10
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-0.54
.;N;.;.;N;.;D;.;N;.;N;N;.;.;N;.;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;N;.;.;N
REVEL
Benign
0.24
Sift
Uncertain
0.024
.;D;.;.;T;.;.;.;T;.;T;T;.;.;T;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;T
Sift4G
Pathogenic
0.0
.;D;.;.;T;.;.;.;T;.;T;T;.;.;T;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;T
Polyphen
0.20
B;.;B;.;B;B;B;B;B;.;B;B;.;.;B;B;B;.;.;.;.;B;B;.;.;.;B;.;.;B;B;.;B;.;B;.;B;B;B;B;B
Vest4
0.60, 0.61, 0.61, 0.60
MutPred
0.21
Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;.;.;.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);
MVP
0.84
MPC
1.1
ClinPred
0.64
D
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.14
gMVP
0.74
Mutation Taster
=25/75
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121913394; hg19: chr3-41266040; COSMIC: COSV62704902; API